Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Daskivich

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Current Opinion in Urology|May 9, 2006
Recent progress in hormonal therapy for advanced prostate cancerTimothy J Daskivich, William K Oh
Urology|June 12, 2016
ProPublica's Surgeon Scorecard: The Argument for Incorporating Appropriateness of Case Selection Into Surgeon Performance AssessmentTimothy J Daskivich, Hyung L Kim
JAMA Internal Medicine|May 5, 2025
Overtreatment in Prostate Cancer: An Overused Term-ReplyTimothy J Daskivich, John T Leppert
Urology Practice|August 18, 2023
Editorial CommentaryTimothy J Daskivich, Mark S Litwin
JAMA Surgery|November 16, 2022
Campaign Reform for US News and World Report RankingsTimothy J Daskivich, Bruce L Gewertz
Cancer|September 12, 2014
Reply to Charlson score and competing mortalityTimothy J Daskivich, Mark S Litwin, Christopher Saigal
Urology|May 16, 2016
Author ReplyTimothy J Daskivich, Mark S Litwin, Christopher Saigal
European Urology|August 28, 2016
Online Ratings Systems for Physicians and Institutions: Limitations of the Current State of the ArtTimothy J Daskivich, Brennan Spiegel, Hyung L Kim
Urology|October 2, 2007
Distinct prognostic role of prostate-specific antigen doubling time and velocity at emergence of androgen independence in patients treated with chemotherapyTimothy J Daskivich, Meredith M Regan, William K Oh
The Journal of Urology|October 31, 2006
Prostate specific antigen doubling time calculation: not as easy as 1, 2, 4Timothy J Daskivich, Meredith M Regan, William K Oh
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Current Opinion in Urology|May 9, 2006
Recent progress in hormonal therapy for advanced prostate cancerTimothy J Daskivich, William K Oh
Urology|June 12, 2016
ProPublica's Surgeon Scorecard: The Argument for Incorporating Appropriateness of Case Selection Into Surgeon Performance AssessmentTimothy J Daskivich, Hyung L Kim
JAMA Internal Medicine|May 5, 2025
Overtreatment in Prostate Cancer: An Overused Term-ReplyTimothy J Daskivich, John T Leppert
Urology Practice|August 18, 2023
Editorial CommentaryTimothy J Daskivich, Mark S Litwin
JAMA Surgery|November 16, 2022
Campaign Reform for US News and World Report RankingsTimothy J Daskivich, Bruce L Gewertz
Cancer|September 12, 2014
Reply to Charlson score and competing mortalityTimothy J Daskivich, Mark S Litwin, Christopher Saigal
Urology|May 16, 2016
Author ReplyTimothy J Daskivich, Mark S Litwin, Christopher Saigal
European Urology|August 28, 2016
Online Ratings Systems for Physicians and Institutions: Limitations of the Current State of the ArtTimothy J Daskivich, Brennan Spiegel, Hyung L Kim
Urology|October 2, 2007
Distinct prognostic role of prostate-specific antigen doubling time and velocity at emergence of androgen independence in patients treated with chemotherapyTimothy J Daskivich, Meredith M Regan, William K Oh
The Journal of Urology|October 31, 2006
Prostate specific antigen doubling time calculation: not as easy as 1, 2, 4Timothy J Daskivich, Meredith M Regan, William K Oh
Pageof 11